Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
YPEL5P2 (Yippee-like 5 pseudogene 2) is a genomic DNA sequence in humans that closely resembles the YPEL5 gene but is classified as a **pseudogene**, meaning it is generally considered **non-functional** and does not encode a functional protein[3][6]. Pseudogenes typically arise through gene duplication or retrotransposition events and subsequently accumulate mutations that disable their coding potential[6]. Although pseudogenes were historically regarded as “junk DNA," some may be transcribed as long non-coding RNAs and have regulatory roles, for example, acting as competitive endogenous RNAs, miRNA decoys, or regulatory elements impacting parental gene expression[2][4]. There is no evidence that YPEL5P2 serves a well-established molecular, physiological, or disease-related function, nor is it described as a therapeutic drug target[3]. Thus, YPEL5P2 does not have known direct biological functions, disease associations, or pharmacological interactions in current scientific literature[3][6]. **Notes on context and conventions:** - The closely related functional gene, YPEL5, is involved in cell proliferation and liver function in model organisms, but YPEL5P2 itself does not share these properties due to its pseudogene status[1]. - Pseudogenes, by definition, are not classified as canonical “receptors,” “enzymes,” “transporters,” or “transcription factors,” and thus are not considered canonical drug targets[6]. - No standardized biomarkers, mechanisms of action, or safety concerns are associated with YPEL5P2. If you require information on the functional gene YPEL5 rather than the pseudogene YPEL5P2, please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Yippee-like 5 pseudogene 2 (YPEL5P2).